Automated Chemistry Analyzer

The BioChem FC-200 Automated Chemistry Analyzer is a fully automated, random access benchtop clinical chemistry analyzer designed for mid-volume laboratories in emerging healthcare markets including district hospitals, regional reference laboratories, and facilities transitioning from semi-automated methods . Operating at up to 240 tests per hour  with random access capability and STAT priority function , this open reagent system  delivers photometric analysis using 8 interference filters (340-670nm)  and disposable cuvette technology (81 cuvettes, 9 strips of 9) that eliminates washing maintenance and cross-contamination concerns .

The analyzer features 40 sample positions, 40 refrigerated reagent positions with continuous 24-hour cooling , sample volume 3-45µL , reaction volume 180-500µL , and independent mechanical mixing . The optical system includes a 12V 20W halogen lamp with 5mm optical path length, absorbance range 0.0-3.5Abs, and resolution 0.0001Abs . Temperature control maintains 37°C (±0.1°C) stability . Calibration modes include factor, linear (one-point, multi-point), and non-linear (Logistic-Log 4P/5P, Exponential 5P, Polynomial 5P, Parabola, Spline) . Quality control features Levey-Jennings charting with Westgard multi-rules .

The system connects to an external PC (Windows XP or higher) via RS-232 or RS-232-to-USB with bi-directional LIS interface for electronic medical record integration . Languages include English, Spanish, Russian, and Ukrainian . Power requirements are 220VAC, 50/60Hz, 1500VA . The unit measures 810 x 1150 mm (W x H) and weighs 145 kg . Water consumption is ≤3 liters/hour .

For the clinical laboratory scientist and pathologist in district hospitals, the BioChem FC-200 delivers accurate measurement of liver function (ALT, AST, ALP, GGT, bilirubin, total protein, albumin), renal function (urea, creatinine, uric acid), lipid profiles (total cholesterol, triglycerides, HDL, LDL, VLDL), cardiac biomarkers (CK, CK-MB, LDH), diabetes markers (glucose), inflammatory markers (CRP, RF, immunoglobulins), and iron studies (iron, TIBC, ferritin). For the patient, rapid, high-volume chemistry results enable early diagnosis of hepatitis, cirrhosis, chronic kidney disease, diabetes, hyperlipidemia, pancreatitis, and myocardial infarction—guiding appropriate medical therapy and preventing disease progression and complications, particularly in emerging healthcare markets where laboratory automation was previously unavailable .